AIMD
Ainos, Inc.
NASDAQ · USHealthcareBiotechnology
$1.59-3.64%
Price as of Jul 20, 2026
AIMD growth
Ainos, Inc. growth
Reported trailing growth, forward expectations and three-year compound growth rates.
Trailing growth
Year over year
- Revenue
- -82.9%
- EBITDA
- +9.1%
- EBIT
- +5.6%
- EPS
- +98.6%
- Free cash flow
- +21.6%
- Operating cash flow
- +21.0%
Forward estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -67.2%
- EBITDA
- +1.8%
- EBIT
- -1.1%
- Net income
- +0.6%
- EPS
- —
- Free cash flow
- +20.2%
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.